Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Bigot

Showing results (51-60 of 138) with videos related to

Pageof 14
Sort By:
BJU International|July 11, 2023
Nephrectomy for kidney tumour increases the risk of de novo arterial hypertensionPierre Bigot, Jean-Christophe Bernhard, Zine-Eddine Khene, et al.
Clinical Genitourinary Cancer|August 5, 2022
Does the Time to Start First-Line Treatment Influence the Survival of Favorable-Risk Patients With Metastatic Renal Cell Carcinoma? Results of the MetaSurv-UroCCR 79 StudyCyrielle Rolley, Philippe Barthelemy, Karim Bensalah, et al.
World Journal of Urology|November 21, 2024
Risk factors for kidney cancer and socio-occupational category: significant impact of chlorinated solvents (UroCCR 111)Matthieu Ferragu, Jean-Christophe Bernhard, Alexis Fontenil, et al.
Frontiers in Endocrinology|June 7, 2024
Ketogenic diet enhances the anti-cancer effects of PD-L1 blockade in renal cell carcinomaJeremy Richard, Céline Beauvillain, Maxime Benoit, et al.
European Urology Oncology|November 4, 2023
Clinical Application of Digital and Computational Pathology in Renal Cell Carcinoma: A Systematic ReviewZine-Eddine Khene, Solène-Florence Kammerer-Jacquet, Pierre Bigot, et al.
European Urology|February 7, 2016
Impact of Body Mass Index, Age, Prostate Volume, and Genetic Polymorphisms on Prostate-specific Antigen Levels in a Control PopulationJean-Nicolas Cornu, Geraldine Cancel-Tassin, David G Cox, et al.
The Journal of Urology|August 6, 2013
Germline genetic variations at 11q13 and 12p11 locus modulate age at onset for renal cell carcinomaFrançois Audenet, Géraldine Cancel-Tassin, Pierre Bigot, et al.
Molecular Medicine (Cambridge, Mass.)|February 11, 2011
Impact of genotyping on outcome of prostatic biopsies: a multicenter prospective studyJean-Nicolas Cornu, Sarah Drouin, Géraldine Cancel-Tassin, et al.
European Urology Focus|February 24, 2021
Percutaneous Ablation Versus Surgical Resection for Local Recurrence Following Partial Nephrectomy for Renal Cell Cancer: A Propensity Score Analysis (REPART Study-UroCCR 71)Marie Brassier, Zine-Eddine Khene, Jean-Christophe Bernhard, et al.
World Journal of Urology|January 10, 2025
Efficacy of immune checkpoint inhibitors in renal cell carcinoma venous tumour thrombus shrinkage (UroCCR 128)Fabien Moinard-Butot, Jonathan Thouvenin, Pierre Bigot, et al.
Pageof 14

Showing results (51-60 of 138) with videos related to

Sort By:
Pageof 14
BJU International|July 11, 2023
Nephrectomy for kidney tumour increases the risk of de novo arterial hypertensionPierre Bigot, Jean-Christophe Bernhard, Zine-Eddine Khene, et al.
Clinical Genitourinary Cancer|August 5, 2022
Does the Time to Start First-Line Treatment Influence the Survival of Favorable-Risk Patients With Metastatic Renal Cell Carcinoma? Results of the MetaSurv-UroCCR 79 StudyCyrielle Rolley, Philippe Barthelemy, Karim Bensalah, et al.
World Journal of Urology|November 21, 2024
Risk factors for kidney cancer and socio-occupational category: significant impact of chlorinated solvents (UroCCR 111)Matthieu Ferragu, Jean-Christophe Bernhard, Alexis Fontenil, et al.
Frontiers in Endocrinology|June 7, 2024
Ketogenic diet enhances the anti-cancer effects of PD-L1 blockade in renal cell carcinomaJeremy Richard, Céline Beauvillain, Maxime Benoit, et al.
European Urology Oncology|November 4, 2023
Clinical Application of Digital and Computational Pathology in Renal Cell Carcinoma: A Systematic ReviewZine-Eddine Khene, Solène-Florence Kammerer-Jacquet, Pierre Bigot, et al.
European Urology|February 7, 2016
Impact of Body Mass Index, Age, Prostate Volume, and Genetic Polymorphisms on Prostate-specific Antigen Levels in a Control PopulationJean-Nicolas Cornu, Geraldine Cancel-Tassin, David G Cox, et al.
The Journal of Urology|August 6, 2013
Germline genetic variations at 11q13 and 12p11 locus modulate age at onset for renal cell carcinomaFrançois Audenet, Géraldine Cancel-Tassin, Pierre Bigot, et al.
Molecular Medicine (Cambridge, Mass.)|February 11, 2011
Impact of genotyping on outcome of prostatic biopsies: a multicenter prospective studyJean-Nicolas Cornu, Sarah Drouin, Géraldine Cancel-Tassin, et al.
European Urology Focus|February 24, 2021
Percutaneous Ablation Versus Surgical Resection for Local Recurrence Following Partial Nephrectomy for Renal Cell Cancer: A Propensity Score Analysis (REPART Study-UroCCR 71)Marie Brassier, Zine-Eddine Khene, Jean-Christophe Bernhard, et al.
World Journal of Urology|January 10, 2025
Efficacy of immune checkpoint inhibitors in renal cell carcinoma venous tumour thrombus shrinkage (UroCCR 128)Fabien Moinard-Butot, Jonathan Thouvenin, Pierre Bigot, et al.
Pageof 14